Top 4 Healthcare REITs Turning Care Into Big Investor Payouts
A number of other research firms have also weighed in on DOC. Mizuho reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Thursday, December 5th. Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a report on Wednesday, January 15th. Wells Fargo & Company decreased their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, December 10th. Wedbush decreased their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 14th. Finally, Robert W. Baird decreased their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $23.92.
Read Our Latest Analysis on DOC
Shares of Healthpeak Properties stock traded down $0.17 during trading on Thursday, hitting $20.03. The company's stock had a trading volume of 3,848,151 shares, compared to its average volume of 4,720,646. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The company has a fifty day simple moving average of $20.21 and a two-hundred day simple moving average of $21.25. The company has a market capitalization of $14.01 billion, a PE ratio of 57.22, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties has a 52 week low of $16.66 and a 52 week high of $23.26.
Large investors have recently added to or reduced their stakes in the business. Mizuho Bank Ltd. bought a new stake in Healthpeak Properties during the fourth quarter valued at approximately $28,000. Harvest Fund Management Co. Ltd bought a new stake in Healthpeak Properties during the fourth quarter valued at approximately $30,000. Avior Wealth Management LLC bought a new stake in Healthpeak Properties during the third quarter valued at approximately $37,000. Groupama Asset Managment bought a new stake in Healthpeak Properties during the third quarter valued at approximately $37,000. Finally, Covestor Ltd grew its position in Healthpeak Properties by 173.8% during the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,152 shares during the period. 93.57% of the stock is currently owned by institutional investors.
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.